Institutional
August 3, 2017
Medical Devices – ANVISA´s Public Consultation to extend the registration term
ANVISA has published, on 08/02/2017, in the Federal Register, the the Public Consultation 371/2017 to discuss the extension, from 5 to 10 years, of medical devices registration term. The measure aims to align ANVISA’s regulation with the provision on Article 12, Paragraph 1th, of Law 6,360/1976, included by Law 13,097/2015.
The Director responsible for the proposal, Mr. Renato Porto, justified it on the absence of risk, considering the already rigorous criteria for registration of Classes 3 and 4 medical devices. Furthermore, he highlighted the scarce denials concerning requests of renewals of such products. According to the Director, by and large, in renewal cases the technical area analysis is merely administrative. Last but not least, the proposal allows medical devices already registered to automatically have an extended term. In other words, the extension is not intended only for products registered after the publication of the new rule.
Access all the issues discussed by the Board of Directors’ Meeting 19/2017 clicking here.
The Public Consultation will be open for 60 days, starting from 08/09/2017. For further clarifications, do not hesitate to contact us through e-mail bio@kasznarleonardos.com
Last related news
December 13, 2024
We present you KL Index: the new platform about Intellectual Property Law evolution in Brazil!
We present you KL Index, a tool that easily provides historical data to analyze the growth of Intellectual Property (IP) in the … We present you KL Index: the new platform about Intellectual Property Law evolution in Brazil!
December 6, 2024
Tarso Machado participates in FICPI’s webinar as a Rising IP Star
Our partner Tarso Machado will participate in the international webinar “Rising IP Stars”, promoted by FICPI – International Federation of Intellectual Property … Tarso Machado participates in FICPI’s webinar as a Rising IP Star
November 28, 2024
We are ranked on Análise Advocacia 2025
We are honored to announce that we have been ranked by Análise Advocacia – 2025 Edition among the most admired firms in … We are ranked on Análise Advocacia 2025